MIR29A Impedes Metastatic Behaviors in Hepatocellular Carcinoma via Targeting LOX, LOXL2, and VEGFA

Primary liver cancer accounts for the third most deadly type of malignant tumor globally, and approximately 80% of the cases are hepatocellular carcinoma (HCC), which highly relies on the activity of hypoxia responsive pathways to bolster its metastatic behaviors. MicroRNA-29a (MIR29A) has been show...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Yang, Ya-Ling, Tsai, Ming-Chao, Chang, Yen-Hsiang, Wang, Chen-Chen, Chu, Pei-Yi, Lin, Hung-Yu, Huang, Ying-Hsien
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8199573/
https://ncbi.nlm.nih.gov/pubmed/34206143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22116001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados